John Tulinsky
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- Axial and Atropisomeric Chirality Synthesis 2
- Asymmetric Synthesis and Catalysis 2
- Co-authors
- Jack W. Singer (7 shared papers)Peter W. de Vries (3 shared papers)Garland Bellamy (1 shared paper)Kent R. Buhler (1 shared paper)Ronald B. Gammill (5 shared papers)Lynn Bonham (3 shared papers)Michael E. Coon (2 shared papers)David Hollenback (3 shared papers)
- Journals
- The Journal of Organic Chemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Expert Opinion on Therapeutic Targets (2 papers)Journal of Controlled Release (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- United States
In The Last Decade
John Tulinsky
13 papers receiving 488 citations
Peers
Comparison fields: 5 of 48
- Biomaterials 211
- Drug Discovery 3
- Pharmaceutical Science 64
- Biochemistry 37
- Organic Chemistry 141
Countries citing papers authored by John Tulinsky
This map shows the geographic impact of John Tulinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Tulinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Tulinsky more than expected).
Fields of papers citing papers by John Tulinsky
This network shows the impact of papers produced by John Tulinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Tulinsky. The network helps show where John Tulinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside John Tulinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 126 | |
| 2 | 2002 | 126 | |
| 3 | 2000 | 61 | |
| 4 | Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. | 2003 | 49 |
| 5 | 2003 | 39 | |
| 6 | 1997 | 37 | |
| 7 | 1998 | 30 | |
| 8 | 1999 | 25 | |
| 9 | 2004 | 24 | |
| 10 | 1998 | 14 | |
| 11 | 1994 | 11 | |
| 12 | 1995 | 7 | |
| 13 | 2003 | 1 |
About John Tulinsky
John Tulinsky is a scholar working on Biomaterials, Organic Chemistry, Pharmaceutical Science, Molecular Biology and Cancer Research, having authored 13 papers that have together received 550 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (4 papers), Cancer therapeutics and mechanisms (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Axial and Atropisomeric Chirality Synthesis (2 papers), Asymmetric Synthesis and Catalysis (2 papers), Advanced Drug Delivery Systems (2 papers), Biopolymer Synthesis and Applications (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Biomaterials (211 citations), Drug Discovery (3 citations), Pharmaceutical Science (64 citations), Biochemistry (37 citations) and Organic Chemistry (141 citations). John Tulinsky has collaborated with scholars based in United States. Frequent co-authors include Jack W. Singer, Peter W. de Vries, Garland Bellamy, Kent R. Buhler, Ronald B. Gammill, Lynn Bonham, Michael E. Coon, David Hollenback, Thayer White and STEPHEN A. MIZSAK. Their work appears in journals such as The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry Letters, Expert Opinion on Therapeutic Targets, Journal of Controlled Release and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.